Danone shares leap as specialized nutrition unit strength fuels Q2 beat

Danone shares jumped over 6% after reporting stronger-than-expected Q2 like-for-like sales growth of 4.1%, significantly surpassing analyst forecasts, driven by robust volume gains across most categories and regions, notably a 15.5% surge in China's specialized nutrition. This strong performance, which analysts noted allayed concerns about category competitiveness, underpins the company's reiterated 2025 organic sales growth guidance of 3-5% and projected moderate margin expansion, despite a minor reported sales miss attributed to currency effects.

Analysis

Danone (DANO) reported a robust second quarter, with shares rising over 6% on the back of stronger-than-expected like-for-like sales growth of 4.1%, which surpassed the 3.8% analyst consensus. The quality of this growth is notable, as it was driven by a significant 3.2% volume increase, well ahead of the 2.5% forecast, indicating strong consumer demand rather than reliance on price hikes. While reported sales of €6.91 billion slightly missed estimates and declined year-over-year, this was attributed to adverse currency effects, a factor often discounted by investors focused on organic performance. The key growth engine was the Specialized Nutrition division, with an 8.7% rise in like-for-like sales, fueled by exceptional performance in the China, North Asia, and Oceania (CNAO) region. In CNAO, comparable sales surged 12.4% on 13.2% volume growth, with the specialized nutrition segment's 15.5% growth crushing Jefferies' 7% forecast. This performance is significant as it mitigates concerns about the category's competitiveness and suggests that competitor issues are company-specific. Despite a slight 0.5% decline in the waters unit, Danone reiterated its full-year 2025 guidance for 3-5% organic sales growth and expects operating profit to outpace revenue, implying moderate margin expansion.

Key Decisions for Investors

• The strong volume-led growth, particularly in the high-margin Chinese specialized nutrition segment, validates the company's strategy and supports a bullish outlook on its ability to meet its reiterated full-year guidance.
• Investors should monitor the performance of the underperforming Waters division and the ongoing impact of foreign exchange rates, as these remain the primary drags on an otherwise strong operational report.
• Given the significant outperformance in China, which analysts believe quashes worries about market-wide weakness, investors should re-evaluate Danone's competitive positioning and potential for market share gains in this key region.